| Literature DB >> 12214016 |
Roberta Borghi1, Luca Pellegrini, Emanuela Lacaná, Alberto Diaspro, Maria Adelaide Pronzato, Antonella Vitali, Roberta Roncarati, Paola Strocchi, Damiano Zaccheo, Luciano D'Adamio, Massimo Tabaton.
Abstract
A series of evidences suggests that enhanced susceptibility to programmed cell death (PCD) is a major pathogenetic factor in Alzheimer's disease (AD). We investigated this issue, analyzing amyloid beta-protein (A beta) production in a model of neuronal PCD, induced by staurosporine in a murine neuroblastoma cell line. When PCD was induced, a 280-290% secreted A beta occurred, in spite of a 20% metabolism and an unchanged A betaPP expression. The increased intracellular A beta reactivity largely colocalized with a marker of ER. Inhibition of caspases blocked the cleavage at the C-terminus of beta PP, but only partially rescued A beta overproduction caused by staurosporine treatment. Our findings suggest that PCD fosters the physiological pathways of A beta production characteristic of neuronal cells, and they confirm the theory that unbalance of PCD is a central event in AD pathogenesis. Moreover, our data indicate that still unidentified cellular mechanisms, other than caspases activation, are responsible of the specific alteration of A betaPP processing during PCD.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12214016 DOI: 10.3233/jad-2002-4104
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472